Quarterly report pursuant to Section 13 or 15(d)

Statements of Operations (Unaudited)

v3.20.2
Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Income Statement [Abstract]        
Revenue
Operating expenses        
Research and development 158,031 284,504 458,726 2,347,746
General and administrative 98,834 51,509 253,210 741,025
Total operating expenses 256,865 336,013 711,936 3,088,771
Loss from operations (256,865) (336,013) (711,936) (3,088,771)
Net loss $ (256,865) $ (336,013) $ (711,936) $ (3,088,771)
Per share information:        
Net loss per common share, basic and diluted $ (0.03) $ (1.15) $ (0.08) $ (13.26)
Weighted average common shares outstanding, basic and diluted 8,788,032 291,780 8,628,958 232,916